Home > Category > Signaling Pathways > Apoptosis > TNF-alpha/TNF Receptor > Ruplizumab (Synonyms: BG 9588; Anti-Human CD40L Recombinant Antibody)

Ruplizumab (Synonyms: BG 9588; Anti-Human CD40L Recombinant Antibody)

ChemLeader 95+%

Catalog No：CLA1059 CAS No.：220651-94-5 MDLNo： Formula： MW：

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
1 mg	3-5days	$730.00	Visible after login	- +
5 mg	3-5days	$2300.00	Visible after login	- +
10 mg	3-5days	$4100.00	Visible after login	- +
50 mg	3-5days	$19000.00	Visible after login	- +
100 mg	3-5days	$34000.00	Visible after login	- +

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Ruplizumab (Synonyms: BG 9588; Anti-Human CD40L Recombinant Antibody)
CAS	220651-94-5
Storage condition	Sealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles

Product details

Ruplizumab (Anti-TNFSF5 / CD40L / CD154) is a humanized monoclonal antibody targeting CD40L(TNF Receptor). It has the potential for systemic lupus erythematosus disease research. MW :145.68 KD.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CLA1059

Ruplizumab (Synonyms: BG 9588; Anti-Human CD40L Recombinant Antibody)

220651-94-5 95+%

CL2831

D-Lin-MC3-DMA | MC3 | DLin-MC3-DMA

1224606-06-7 98+%

CLA1270

Onartuzumab (Anti-HGFR / c-Met)

1133766-06-9 95+%